1. Home
  2. SOPH vs CION Comparison

SOPH vs CION Comparison

Compare SOPH & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SOPHiA GENETICS SA

SOPH

SOPHiA GENETICS SA

HOLD

Current Price

$4.98

Market Cap

374.1M

Sector

Health Care

ML Signal

HOLD

CION

CION Investment Corporation

HOLD

Current Price

$6.68

Market Cap

384.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOPH
CION
Founded
2011
2011
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
374.1M
384.8M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
SOPH
CION
Price
$4.98
$6.68
Analyst Decision
Strong Buy
Sell
Analyst Count
2
1
Target Price
$7.50
$7.00
AVG Volume (30 Days)
88.5K
547.6K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
15.96%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.09
N/A
Revenue Next Year
$19.57
N/A
P/E Ratio
N/A
$17.55
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$6.50
52 Week High
$5.70
$10.93

Technical Indicators

Market Signals
Indicator
SOPH
CION
Relative Strength Index (RSI) 51.48 42.09
Support Level $4.54 $6.55
Resistance Level $5.29 $7.27
Average True Range (ATR) 0.28 0.17
MACD 0.01 0.03
Stochastic Oscillator 71.64 28.57

Price Performance

Historical Comparison
SOPH
CION

About SOPH SOPHiA GENETICS SA

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.

About CION CION Investment Corporation

CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Companies portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.

Share on Social Networks: